
    
      Apatinib is a VEGFR targeting tyrosine kinase inhibitor, which has preliminary demonstrated
      the efficacy and safety in treatment of advanced hepatocellular carcinoma by phase II stage
      research. Pulmonary metastasis of hepatocellular cancer is one of the difficulties in
      clinical practice,because it's not sensitive to systemic chemotherapy.This phase â…¢ study aims
      to evaluates the efficacy and safety of the Apatinib in the treatment of advanced
      hepatocellular cancer with pulmonary metastasis.
    
  